Ellie MD has two of the ingredients that matter most on this list. It offers hormone therapy, and it titrates by response over 12-week cycles rather than pushing everyone up a fixed ladder. Either alone would lift a provider above the async baseline.
The frustration is that they are run as separate services. The hormone side and the weight side sit in different tracks, and nothing published joins them into a single view of a patient whose weight and whose cycles are driven by the same underlying mechanism. The pieces are here; the assembly is not.
Here is how Ellie MD reads against each part of The Root Eight for women with PCOS (PMOS). Each dimension is marked none, partial, or strong; price is shown but is never part of the rating.
How the 12-week cycle works
Titration is organised in 12-week blocks with adjustment based on how you respond, backed by 503A compounding — which is why the dosing dimension is the strongest row on this scorecard. At $239 that is competitively priced for response-based care. Androgen fluency and lab depth score at partial: the capability exists within the practice, but there is no published PMOS protocol directing it.
Two services, one patient
Because the hormone and weight tracks are separate, joining them is largely your job. That is workable if you are an organised, well-informed patient who can carry context between them, and harder if you were hoping to hand the whole picture to one team. Ellie MD also publishes no maintenance or step-down plan, so the final phase is unaddressed — which is what pulls the rating down more than any weakness in the dosing itself.
Ellie MD may suit you if
- You want response-based titration rather than a fixed schedule, at a mid-range price.
- You are already clear on your own PMOS picture and can direct your care.
- Access to hormone therapy in the same practice is useful to you even if unintegrated.
Look elsewhere if
- You want one team holding the whole picture rather than two tracks you coordinate.
- A published plan for maintenance and coming off is a requirement.
- You want the insulin mechanism to lead the treatment plan.
What to ask before you enrol
Take these to Ellie MD directly. Any provider worth joining will answer them in writing.
- Do the hormone and weight sides share notes, or do I brief each separately?
- What specifically triggers a dose change inside a 12-week cycle?
- Which labs do you run at intake, and is fasting insulin among them?
- What is the plan once I reach a weight I want to hold?
Our read
Ellie MD scores mid-table because it does the dosing part genuinely well and leaves the integration and the endgame to you. If you want response-based titration at a fair price and are willing to be your own case manager, the clinical substance here is real.
Everything above is drawn from what this provider publishes, and providers change their terms without announcing it — treat the figures as a starting point and confirm them yourself. Lantana is editorial, not clinical: nothing here is medical advice or a substitute for your own clinician.